AAOI
Applied Optoelectronics, Inc.
AAOI offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
CEVA
CEVA, Inc.
CEVA has a slight edge over AAOI overall, supported by lower modeled downside.
AAOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
AAOI's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CEVA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Strong |
CEVA's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
AAOI PE Valuation
AAOI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
CEVA PE Valuation
CEVA has no meaningful PE right now: it lost money over the past year.
AAOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AAOI to return to profit, with revenue growing. However, they disagree widely on these estimates.
CEVA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CEVA, with profitability improving. However, they disagree widely on these estimates.
AAOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.98 | — |
| Q3 2026 | -$0.42 | +$3.02 |
| Q2 2026 | -$0.77 | +$2.81 |
| Q1 2026 | -$0.65 | +$3.43 |
| Q4 2025 | -$0.64 | +$3.86 |
| Q3 2025 | -$3.44 | -$1.41 |
| Q2 2025 | -$3.58 | -$1.70 |
| Q1 2025 | -$4.08 | -$2.29 |
| Q4 2024 | -$4.50 | -$2.75 |
AAOI is still losing money, but far less than before: $0.42 per share over the past year, against $4.50 at its worst in late 2024.
CEVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.74 | — |
| Q3 2026 | -$0.39 | +$0.07 |
| Q2 2026 | -$0.41 | +$0.01 |
| Q1 2026 | -$0.46 | -$0.18 |
| Q4 2025 | -$0.44 | -$0.07 |
| Q3 2025 | -$0.46 | -$0.32 |
| Q2 2025 | -$0.42 | -$0.13 |
| Q1 2025 | -$0.28 | +$0.25 |
| Q4 2024 | -$0.37 | +$0.14 |
CEVA is still losing money, but far less than before: $0.39 per share over the past year, against $1.34 at its worst in mid-2023.
AAOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $269.9M | +127% |
| Q2 2026 | $191.9M | +86% |
| Q1 2026 | $151.1M | +51% |
| Q4 2025 | $134.3M | +34% |
| Q3 2025 | $118.6M | +82% |
| Q2 2025 | $103M | +138% |
| Q1 2025 | $99.9M | +146% |
| Q4 2024 | $100.3M | +66% |
AAOI has the edge over CEVA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +15 points |
| Q2 2026 | -13% | +2.6 points |
| Q1 2026 | -8.6% | +0.3 points |
| Q4 2025 | -8.6% | -2.1 points |
| Q3 2025 | -15% | +10 points |
| Q2 2025 | -16% | +45 points |
| Q1 2025 | -8.9% | +44 points |
| Q4 2024 | -6.5% | +1 points |
AAOI has the edge over CEVA on profitability, with a higher operating margin.
CEVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $29.1M | +2.4% |
| Q2 2026 | $29M | +13% |
| Q1 2026 | $27M | +11% |
| Q4 2025 | $31.3M | +7.1% |
| Q3 2025 | $28.4M | +4.3% |
| Q2 2025 | $25.7M | -9.7% |
| Q1 2025 | $24.2M | +9.8% |
| Q4 2024 | $29.2M | +21% |
CEVA's revenue has grown year over year for five quarters in a row: $29M last quarter, up 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | -4.8 points |
| Q2 2026 | -7.2% | +10 points |
| Q1 2026 | -19% | -0.8 points |
| Q4 2025 | -1.3% | -1.5 points |
| Q3 2025 | -7.3% | +2.3 points |
| Q2 2025 | -17% | -17 points |
| Q1 2025 | -18% | +4.4 points |
| Q4 2024 | 0.3% | +12 points |
CEVA's operating margin was −12% last quarter, down 4.8 points from the same quarter a year ago.
AAOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$369.9M | -$291.2M |
| Q2 2026 | -$265.3M | -$174.4M |
| Q1 2026 | -$143.6M | -$64.3M |
| Q4 2025 | -$104.6M | -$51.6M |
| Q3 2025 | -$78.7M | -$58M |
| Q2 2025 | -$91M | -$86M |
| Q1 2025 | -$79.3M | -$45.1M |
| Q4 2024 | -$53M | -$48.4M |
AAOI has burned cash in almost every quarter: −$883M over the past year, against −$302M the year before.
CEVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $434K | +$6.7M |
| Q2 2026 | $5.2M | +955% |
| Q1 2026 | -$7.2M | +$515K |
| Q4 2025 | $7.2M | +3.1% |
| Q3 2025 | -$6.3M | -$6.3M |
| Q2 2025 | $492K | -72% |
| Q1 2025 | -$7.7M | +$539K |
| Q4 2024 | $7M | +73% |
CEVA has the edge over AAOI on cash generation, producing positive trailing cash flow while its opponent burns cash.
AAOI Net Leverage
AAOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CEVA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -42.2x | Net Cash |
| Q3 2022 | -8.0x | Net Cash |
| Q2 2022 | -2.0x | Net Cash |
| Q1 2022 | -3.5x | Net Cash |
| Q4 2021 | -3.5x | Net Cash |
| Q3 2021 | -3.3x | Net Cash |
| Q2 2021 | -3.2x | Net Cash |
| Q1 2021 | -10.5x | Net Cash |
CEVA has more cash than debt.
AAOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.8 | Oversold |
AAOI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
CEVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 25.4 | Neutral |
CEVA's weekly RSI is 43 (neutral) and its Stochastic is 25 (neutral).
AAOI PE vs Technology Sector
AAOI has no meaningful PE right now: it lost money over the past year.
CEVA PE vs Technology Sector
| Metric | CEVA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CEVA has no meaningful PE right now: it lost money over the past year.
AAOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.2 | 34% below |
| 20 week MA | $100.6 | 47% below |
| 50 week MA | $100.3 | 47% below |
| 100 week MA | $62.3 | 15% below |
| 200 week MA | $36.9 | 43% above |
AAOI has fallen below most of its moving averages, though it's still 43% above its 200-week average.
CEVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.7 | 14% below |
| 20 week MA | $32.6 | 19% below |
| 50 week MA | $29.4 | 11% below |
| 100 week MA | $27.7 | 4.9% below |
| 200 week MA | $25.7 | 2.3% above |
CEVA has fallen below most of its moving averages, though it's still 2.3% above its 200-week average.
AAOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $8.77 | -24% |
| 2021 | $8.77 | $5.64 | -36% |
| 2022 | $5.64 | $1.95 | -65% |
| 2023 | $1.95 | $19.3 | +891% |
| 2024 | $19.3 | $37.7 | +95% |
| 2025 | $37.7 | $37.2 | -1.5% |
| 2026 YTD | $37.2 | $52.9 | +42% |
AAOI has the edge over CEVA on returns for 2026, with the stronger performance.
CEVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.1 | $42.2 | +56% |
| 2021 | $42.2 | $44.4 | +5.1% |
| 2022 | $44.4 | $25.9 | -42% |
| 2023 | $25.9 | $22.7 | -12% |
| 2024 | $22.7 | $32.4 | +43% |
| 2025 | $32.4 | $21.7 | -33% |
| 2026 YTD | $21.7 | $26.3 | +21% |
CEVA has finished lower in three of the last six years. It's up 21% so far in 2026.